Calidi BiotherapeuticsCLDI
13F holders, Q2 2024 (June 30)2holders
$0.20avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings. The largest holders were Driehaus Capital Management LLC ($19K) and Marshall Wace, LLP ($12K).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $31K |
| Exits | 0 | $0 |
Ownership 2 holders
| Driehaus Capital Management LLC | 0.00% | New | 94,697 | $19K |
| Marshall Wace, LLP | 0.00% | New | 61,869 | $12K |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.